论文信息 - Acquired C1 inhibitor deficiency: should we monitor for associated antibody deficiency? - 字舞流文

Acquired C1 inhibitor deficiency: should we monitor for associated antibody deficiency?

H. Longhurst | S. Grigoriadou | M. Buckland | I. Chua | A. Tohani

[1] E. Gelfand. Intravenous immune globulin in autoimmune and inflammatory diseases. , 2012, The New England journal of medicine.

[2] P. Pundir,et al. Comparison of the inhibitory effects of resveratrol and tranilast on IgE, 48/80 and substance P dependent-mast cell activation , 2010, Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology.

[3] M. Cicardi,et al. Lymphoproliferative disease and acquired C1 inhibitor deficiency. , 2007, Haematologica.

[4] A. Chiocchetti,et al. Cutaneous Manifestations as Presenting Sign of Autoimmune Lymphoproliferative Syndrome in Childhood , 2005, Dermatology.

[5] M. Cicardi,et al. Autoantibodies and Lymphoproliferative Diseases in Acquired C1-Inhibitor Deficiencies , 2003, Medicine.

[6] J. Piette,et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. , 2002, American Journal of Medicine.